The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Life Science Pharmaceuticals
Consulting or Advisory Role - Life Science Pharmaceuticals
Research Funding - Abbvie; Avipep; Daiichi Sankyo
Patents, Royalties, Other Intellectual Property - Abbvie; Kalobios; Life Science Pharmaceuticals; Ludwig Institute for Cancer Research
Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM).
 
Hui K. Gan
Honoraria - Merck Serono; Pfizer
Research Funding - Abbvie
Other Relationship - Ludwig Institute for Cancer Research
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Novartis (Inst); Onyx (Inst); Sanofi (Inst)
 
Lisa Fichtel
No Relationships to Disclose
 
Andrew B. Lassman
Consulting or Advisory Role - Agenus; Amgen; Celgene; Foundation Medicine; Genentech/Roche; HERON; Midatech Pharma; Novartis; RadMD; Sigma-Tau; Stemline Therapeutics
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Celldex (Inst); E-therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Plexxikon (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Novartis; Novocure
 
Ryan Merrell
No Relationships to Disclose
 
Martin J. Van Den Bent
Research Funding - Abbvie; Roche Pharma AG
 
Priya Kumthekar
No Relationships to Disclose
 
Andrew M. Scott
No Relationships to Disclose
 
Michelle Pedersen
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Erica J. Gomez
Employment - Abbvie
 
Judee S. Fischer
Employment - Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbott Diagnostics; Abbott Diagnostics (I); Abbvie; Abbvie (I)
 
William Ames
Employment - Abbott Diagnostics; Abbvie
 
Hao Xiong
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ho-Jin Lee
Employment - Abbvie
Stock and Other Ownership Interests - Acadia Pharmaceuticals (I); Regeneron (I); Sarepta Therapeutics (I); Vertex (I)
 
Wijith Munasinghe
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Lisa Roberts-Rapp
Employment - Abbott Laboratories; Abbott Laboratories (I); Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbott Diagnostics; Abbvie
Patents, Royalties, Other Intellectual Property - Abbott Diagnostics
 
Peter Ansell
Employment - Abbvie; Abbvie (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
Honoraria - Abbvie
Patents, Royalties, Other Intellectual Property - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Kyle D. Holen
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Rose Lai
Employment - Abbvie
Leadership - Abbvie
Stock and Other Ownership Interests - Abbvie
 
David A. Reardon
Honoraria - Amgen; Merck; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Merck; Novartis; Roche/Genentech
Speakers' Bureau - Merck; Roche Pharma AG
Research Funding - Celldex; Incyte